Patient Reported Outcomes (PRO) and Tolerability of Capivasertib (Capi) plus Abiraterone (Abi) versus Placebo (Pbo) plus Abi in Patients (Pts) with PTEN-Deficient Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): CAPItello-281

Simple item page
dc.contributor.author George, Daniel J.
dc.contributor.author De Santis, Maria
dc.contributor.author Clarke, Noel W.
dc.contributor.author Fay, Andre P.
dc.contributor.author Urun, Yuksel
dc.contributor.author Fizazi, Karim
dc.contributor.author Uemura, Hirotsugu
dc.date.accessioned 2026-04-25T10:19:15Z
dc.date.available 2026-04-25T10:19:15Z
dc.date.issued 2026-03-01
dc.description.sponsorship AstraZeneca
dc.identifier.doi 10.1200/JCO.2026.44.7_suppl.14
dc.identifier.issn 0732-183X
dc.identifier.issn 1527-7755
dc.identifier.uri https://hdl.handle.net/20.500.14365/9035
dc.identifier.uri https://doi.org/10.1200/JCO.2026.44.7_suppl.14
dc.language.iso en
dc.publisher Lippincott Williams & Wilkins
dc.relation.ispartof ASCO Genitourinary Cancers Symposium -- FEB 26-28, 2026 -- San Francisco, CA
dc.rights info:eu-repo/semantics/closedAccess
dc.title Patient Reported Outcomes (PRO) and Tolerability of Capivasertib (Capi) plus Abiraterone (Abi) versus Placebo (Pbo) plus Abi in Patients (Pts) with PTEN-Deficient Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): CAPItello-281
dc.type Conference Object
dspace.entity.type Publication
gdc.author.wosid Ürün, Yüksel/AAQ-3612-2020
gdc.description.department
gdc.description.departmenttemp Duke Canc Inst, Durham, NC USA; Univ Manchester, Christie & Salford Royal NHS Fdn Trusts, Manchester Canc Res Ctr, Manchester, England; Charite Univmed Berlin, Berlin, Germany; Med Univ Vienna, Berlin, Germany; Kindai Univ Hosp, Osaka, Japan; Hosp Nora Teixeira, Porto Alegre, Brazil; PUCRS Sch Med, Porto Alegre, Brazil; Ankara Univ, Sch Med, Ankara, Turkiye; Izmir Univ Econ, Med Point Hosp, Izmir, Turkiye; Univ Ulsan, Asan Med Ctr, Seoul, South Korea; Natl Canc Ctr, Goyang, South Korea; Wenzhou Coll, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China; UMHAT Sofiamed, Sofia, Bulgaria; Fdn Estudios Clin, Santa Fe, Argentina; AstraZeneca, Gaithersburg, MD USA; AstraZeneca, Macclesfield, England; AstraZeneca, Cambridge, England; Univ Paris Saclay, Inst Gustave Roussy, Ctr Oscar Lambret, Lille, France
gdc.description.issue 7_SUPPL
gdc.description.publicationcategory Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
gdc.description.volume 44
gdc.description.woscitationindex Science Citation Index Expanded - Conference Proceedings Citation Index - Science
gdc.identifier.wos WOS:001729941200041
gdc.index.type WoS
relation.isOrgUnitOfPublication e9e77e3e-bc94-40a7-9b24-b807b2cd0319
relation.isOrgUnitOfPublication.latestForDiscovery e9e77e3e-bc94-40a7-9b24-b807b2cd0319

Files

Collections

WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection